| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2534bb9f13460c6429c25acf8df25d0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 |
| filingDate |
2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b059977680f38d27c675322d07cee55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a3eeb9cd691e3f2df5778b598c9ae9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e944bea2c49dc733c9d0f58706b802cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b4bf4fbbf7af38094106b692979ff5e |
| publicationDate |
2015-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-605516-A |
| titleOfInvention |
Sustained-release therapeutic agent for hypertension and renal dysfunction |
| abstract |
Disclosed is a therapeutic agent or prophylactic for hypertension or normal high blood pressure and renal dysfunction that is more effective than conventional drugs. Specifically disclosed is a sustained-release pharmaceutical composition for the treatment or prevention of hypertension or normal high blood pressure and renal dysfunction and which contains a 2-phenylthiazole compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active component. The composition maintains an effective blood level for a period of at least 13 hours. Example of a compound of formula (I) is 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole carboxylic acid (febuxostat). |
| priorityDate |
2010-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |